4.5 Review

Immunology in the clinic review series; focus on type 1 diabetes and viruses: the innate immune response to enteroviruses and its possible role in regulating type 1 diabetes

Journal

CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Volume 168, Issue 1, Pages 30-38

Publisher

WILEY
DOI: 10.1111/j.1365-2249.2011.04557.x

Keywords

enterovirus; innate immunity; interferon; RIG-I-like receptors; Type 1 diabetes

Categories

Funding

  1. Karolinska Institutet, Stockholm, Sweden
  2. Swedish MRC
  3. Swedish Diabetes Association Research Foundation
  4. Swedish Child Diabetes Foundation
  5. European Union
  6. European Foundation for the Study of Diabetes
  7. Oxford University, Oxford, U.K.

Ask authors/readers for more resources

Type 1 diabetes (T1D) is an autoimmune disease arising as a consequence of a misdirected T cell response to the pancreatic beta cell. In recent years, there has been a growing interest in the innate immune system as a regulator of disease development. Genome-wide association studies have identified diabetes-associated polymorphisms in genes encoding proteins with functions related to the innate immune response. Moreover, enteroviruses, known to activate a strong innate immune response, have been implicated in the disease pathogenesis. In this review, we discuss the innate immune response elicited by enteroviruses and how this response may regulate T1D development.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available